Sharemaestro Newsreel

ResMed (RMD) Faces An Earnings Test After A Rebound That Still Looks Undervalued

ResMed (RMD) is approaching its next earnings report with Wall Street anticipating $2.90 per share and $1.46 billion in revenue. Despite recent share price gains, the stock remains undervalued according to the most popular narrative, which sets a fair value of $247.93 compared to …

Becton Dickinson (BDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Azenta, Inc. Stock 12‑Month Price Target Raised to $33.8, Implies 12% Upside

Azenta, Inc.'s stock price target has been increased from $27.8 to $33.8 by five analysts, implying a 12% potential upside based on its August 4th closing price. The consensus rating for the stock remains a "Buy" from six analysts. Investors can find more detailed …

Form 8K Bausch & Lomb Corp For: 6 August By Investing.com

Bausch & Lomb Corp filed a Form 8K on August 6, 2026. The article from Investing.com announces this filing but does not provide further details regarding the content of the Form 8K.

Bausch + Lomb Announces Board of Directors Update, Reaffirms Guidance

Bausch + Lomb (NYSE/TSX: BLCO) announced changes to its Board of Directors, with four new appointments effective August 5, 2026, at the request of majority owner Bausch Health Companies Inc. The company also reaffirmed its full-year 2026 guidance for revenue between $5.440 billion and …

Becton, Dickinson and Company 2026 Q3 - Results - Earnings Call Presentation (NYSE:BDX) 2026-08-06

This article announces the publication of Becton, Dickinson and Company's (BDX) Q3 2026 earnings call presentation. The slide deck was released in conjunction with their earnings call, providing details on their financial results for the quarter. The publication is handled by Seeking Alpha's transcripts …

Becton Dickinson (BDX) Q3 Earnings and Revenues Surpass Estimates

Becton Dickinson (BDX) reported Q3 earnings of $3.23 per share and revenues of $4.98 billion, both exceeding Zacks Consensus Estimates. Despite outperforming expectations for the past four quarters, the stock has underperformed the S&P 500 this year, leading to a Zacks Rank #4 (Sell) …

Warby Parker Inc. (WRBY) Surpasses Q2 Earnings Estimates

Teleflex (TFX) Surpasses Q2 Earnings and Revenue Estimates

RXST: Entered a $60M+ collaboration with Alcon as product sales declined and leadership transitioned

RxSight, Inc. (RXST) reported flat revenue for Q2 2026, with collaboration revenue offsetting a decline in product sales, resulting in a net loss of $12.1M. The company secured a significant collaboration with Alcon, including a $60M upfront payment, potential milestones of $140M, and 30% …

Zacks Research Reduces Earnings Estimates for AngioDynamics

Becton, Dickinson and Company Releases Q3 2026 Financial Results

Becton, Dickinson and Company reported stronger-than-expected Q3 2026 financial results, with adjusted earnings per share of $3.23 exceeding estimates and revenue reaching $4.98 billion. The company saw robust growth in its Interventional segment, and management provided optimistic guidance for the full fiscal year 2026. …

Why is Becton Dickinson stock climbing today?

Becton Dickinson (BDX) stock rose 1.8% in pre-open trading after the medical technology company reported fiscal Q3 2026 earnings that surpassed Wall Street expectations for both revenue and EPS. The company also raised its full-year fiscal 2026 adjusted diluted EPS guidance, signaling increased confidence …

Nyxoah: Revenue increased to €14M in H1, operating loss stable

Warby Parker (NYSE:WRBY) Misses Q2 CY2026 Revenue Estimates

BioLife Solutions set to report earnings under takeover cloud

BioLife Solutions is set to report second-quarter earnings under the shadow of a $1.5 billion acquisition agreement by Repligen Corporation. Analysts have largely downgraded BioLife's stock to "Hold" with price targets around the acquisition price of $31 per share. Investors will be focused on …

California State Teachers Retirement System Buys 145,045 Shares of Avantor, Inc. $AVTR

The California State Teachers Retirement System increased its stake in Avantor, Inc. (NYSE:AVTR) by 22.6% in the first quarter, purchasing an additional 145,045 shares to bring its total holding to 785,799 shares valued at $6.16 million. Several other institutional investors also adjusted their positions …

Form 144 ResMed INC For: 6 August By Investing.com

This article announces the filing of Form 144 for ResMed INC on August 6. Form 144 indicates an intent to sell restricted securities. The brief article, published by Investing.com, provides no further details beyond the filing announcement.

Form 4 Anteris Technologies Global Corp. For: 6 August By Investing.com

This article announces the filing of Form 4 by Anteris Technologies Global Corp. on August 6. It appears to be a brief news item indicating a regulatory filing by the company, with no further details provided in the body of the text. The content …

L1 Capital sells 495,189 Anteris Technologies Global Corp. (AVR) shares

L1 Capital Pty Ltd, a ten percent owner of Anteris Technologies Global Corp. (AVR), reported indirect sales of 495,189 common shares over two days in early August 2026. The sales occurred at prices ranging from $8.23 to $8.30 per share. Following these transactions, L1 …

Becton Dickinson beats estimates, raises guidance midpoint

Becton Dickinson and Company (NYSE:BDX) reported third-quarter results that surpassed analyst expectations for both earnings per share and revenue. The company posted adjusted EPS of $3.23 on revenue of $5.0 billion, exceeding estimates of $3.13 and $4.89 billion, respectively. Following these strong results, Becton …

Bausch Health requests four new Bausch + Lomb directors with about 87% stake

Warby Parker Q2 2026 Earnings: Tariff Refunds Lift Profitability

Warby Parker (NYSE: WRBY) reported improved Q2 2026 financial results, with diluted EPS turning positive and revenue up 9.8% year-over-year. The profitability boost was largely driven by an $11.8 million tariff-refund benefit, which offset increased spending on store expansion and preparations for the Intelligent …

TELEFLEX ($TFX) Releases Q2 2026 Earnings

Teleflex Inc (TFX) reported better-than-expected Q2 2026 revenue, adjusted margins, and EPS, driven by strong vascular and surgical performance and significant proceeds from an OEM divestiture. However, the company reduced its 2026 pro forma adjusted constant currency revenue growth guidance due to slower-than-expected integration …

Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board

Bausch Health Companies Inc. announced that its CEO, Thomas J. Appio, has been appointed to the board of directors of its subsidiary, Bausch + Lomb Corporation, effective August 5, 2026. This appointment, along with the addition of three other new directors, was requested by …

Earnings Flash (BDX) Becton, Dickinson and Company Reports Q3 Revenue $4.98B

Becton, Dickinson and Company (BDX) reported its Q3 revenue at $4.98 billion. The company also expects its fiscal 2026 adjusted EPS to range from $12.62 to $12.72, aligning with FactSet estimates. Recent analyst activities include price target adjustments and new coverage with a "Buy" …

Warby Parker Down Nearly 13%, On Track for Largest Percent Decrease Since February 2024 -- Data Talk

Warby Parker, Inc. Class A (WRBY) shares dropped nearly 13% to $25.50, marking its largest percentage decrease since February 2024. The stock is on track for its lowest close since July 2026 and has fallen for two consecutive days. Despite these recent declines, WRBY …

Earnings Flash (TFX) Teleflex Incorporated Reports Q2 Revenue $570.3M, Vs. FactSet Est of $559.6M

Teleflex Incorporated (TFX) reported its second-quarter revenue, reaching $570.3 million. This figure exceeded FactSet's estimated revenue of $559.6 million. The announcement provides key financial data for investors and market analysts.

Quantinno Capital Management LP Sells 23,263 Shares of Teleflex Incorporated $TFX

Quantinno Capital Management LP reduced its stake in Teleflex Incorporated by 30.2% in the first quarter, selling 23,263 shares and retaining 53,766 shares valued at approximately $6.4 million. Despite mixed analyst ratings, with an overall "Hold" consensus and an average price target of $148.90, …

Teleflex Reports Second Quarter Financial Results and Full Year 2026 Outlook

Does Higher EPS Guidance In Sleep And Breathing Health Shift The Bull Case For ResMed (RMD)?

Baxter (BAX): Buy, Sell, or Hold Post Q2 Earnings?

Baxter (BAX) Stock May Be 25% Undervalued As Q2 Outlook Improves

LeMaitre Vascular (LMAT) Stock Price Hit By Revenue Guidance Cut

Lazard Asset Management LLC Has $734,000 Stock Position in ResMed Inc. $RMD

Lazard Asset Management LLC significantly reduced its stake in ResMed Inc. by 68% in the first quarter, selling 6,948 shares but retaining 3,272 shares valued at approximately $734,000. Institutional investors now collectively own 54.98% of ResMed. The article also notes recent insider selling by …

Nephros Q2 2026 Earnings: Revenue Rises 36% as Tariff Refund Lifts Margins

Nephros reported a 36% increase in Q2 2026 net revenue to $6.017 million, with diluted EPS rising to $0.11, significantly boosted by a one-time $0.6 million tariff refund. While the refund inflated profitability, core programmatic revenue still grew 27%, and service-related revenue nearly tripled. …